Evidence map›Paper›PMID 42105166›Full record

ReviewInternational ophthalmology2026

Intriguing roles of Müller glia: a special emphasis on the development and pathology of Müller glia cells in the retina.

Priti Gupta, T S Gopenath, Sandeep Kumar Singh

Abstract readReview
PubMed Publisher
In one paragraph

Review in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Priti GuptaDepartment of Biotechnology, School of Life Sciences, JSS Academy of Higher Education & Research, Mysore, India.
T S GopenathDepartment of Biotechnology, School of Life Sciences, JSS Academy of Higher Education & Research, Mysore, India. gopenath@jssuni.edu.in.
Sandeep Kumar SinghDepartment of Medical Biotechnology, All India Institute of Medical Sciences (AIIMS) Nagpur, Nagpur, Maharashtra, 441108, India. sandeeps.bhu@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aspiration of this review is to discuss the intricate development of Müller glial cells (MGCs) and their indispensable neuroprotective and regenerative roles, as well as novel avenues of treatment for retinal neurodegenerative diseases. MGCs are the principal radial glial cells of the vertebrate retina, extending from what is composed of a characteristic funnel-shaped morphology spanning throughout the retinal thickness. Their cell bodies are in the inner nuclear layer (INL), and their processes span from the outer limiting membrane to the inner limiting membrane, where they strongly associate with neurons, blood vessels, and the extracellular matrix across all layers of retinal structure. These cells preserve ionic and water homeostasis, control neurotransmitter uptake, and participate in constructing the blood retinal barrier (BRB), as well as deliver crucial metabolic help to neurons by means of the glutamate-glutamine cycle, thus excluding excitotoxic injury.

methodsFirst, we analysed the molecular processes underlying MGCs activation: pro-inflammatory molecules, Reactive oxygen species (ROS), and survival pathways. Special notice was made of changes in gene expression upon activation and the recrudescence of embryonic developmental programs that permit cell-cycle re-entry and retinal regeneration. Systematic searches of Google Scholar and PubMed to find relevant literature.

resultsUpon activation, Müller's glia, a type of retinal support cell, commence the expression of protective genes, such as Zfp36, Mt1, and Slc14a1. Some creatures could regenerate; however, in mammals, this capacity is limited, which is particularly evident in the retina, where, despite the activation of Müller's glia, full regeneration of damaged photoreceptors is not achieved. MGCs produces retinal progenitors that assist photoreceptors and interneurons while maintaining retinal integrity. MGCs contain progenitor cells that can differentiate into both neurons and other retinal cell types. Molecular targets for retinal therapeutics that utilize MGCs include pathways that regulate inflammation and oxidative stress.

conclusionMüller glial cells are essential for maintaining retinal health, safeguarding neurons, and facilitating their regeneration. Targeted molecular therapy is addressed as a promising strategy for retinal neurodegenerative diseases, using their regenerative and protective potential.

Indexed as

Ependymoglial CellsRetinaRetinal DiseasesAnimalsHumansCellular reprogrammingMüller cellsNeuroprotectionRetinal disordersRetinal regenerationTherapeutic interventions

Identifiers

PMID42105166

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.